TPC
EQ icon

Takeda Pharmaceutical Company’s Equillium EQ Stock Holding History

Takeda Pharmaceutical Company’s Portfolio EQ Stock Details EQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.61M Hold
1,824,977
– – 15.94% 2
2025
Q2 		$575K Hold
1,824,977
– – 2.94% 5
2025
Q1 		$712K Hold
1,824,977
– – 4.4% 4
2024
Q4 		$1.37M Hold
1,824,977
– – 5.15% 4
2024
Q3 		$1.51M Hold
1,824,977
– – 3.99% 5
2024
Q2 		$1.26M Hold
1,824,977
– – 0.54% 9
2024
Q1 		$4.22M Hold
1,824,977
– – 1.46% 7
2023
Q4 		$1.31M Buy
+1,824,977
New +$1.08M 0.4% 9

Other funds holding EQ

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Takeda Pharmaceutical Company's EQ Position: Q3 2025 in Review

Takeda Pharmaceutical Company held its Equillium (EQ) position steady in Q3 2025 at 1,824,977 shares worth $2.61M. The position accounts for 15.94% of the portfolio, ranked #2.

Takeda Pharmaceutical Company first reported a position in EQ in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.22M in Q1 2024. 40 funds tracked by Wall St. Rank hold EQ as of Q3 2025.

  • Takeda Pharmaceutical Company held 1,824,977 shares of Equillium worth $2.61M as of Q3 2025.
  • Takeda Pharmaceutical Company left its Equillium share count unchanged in Q3 2025.
  • Equillium made up 15.94% of Takeda Pharmaceutical Company's portfolio in Q3 2025, its #2 holding.
  • Takeda Pharmaceutical Company first reported a position in Equillium in Q4 2023 and has held it in 8 quarters since.
  • Takeda Pharmaceutical Company's Equillium position peaked at $4.22M in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Equillium as of Q3 2025.

Based on Takeda Pharmaceutical Company's 13F filing for Q3 2025, filed 13 Nov 2025.